Botanix Sb Drug Patent Portfolio
Botanix Sb owns 1 orange book drug protected by 20 US patents Given below is the list of Botanix Sb's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11566000 | Crystalline form of sofpironium bromide and preparation method thereof | 22 May, 2040 | Active |
| US11584715 | Crystalline form of sofpironium bromide and preparation method thereof | 22 May, 2040 | Active |
| US11123325 | Formulation for soft anticholinergic analogs | 20 Jul, 2037 | Active |
| US10947192 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US10952990 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US10959983 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US10961191 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US11026919 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US11034652 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US11052067 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US11084788 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US12156865 | Formulation for soft anticholinergic analogs | 22 May, 2034 | Active |
| US12357609 | Formulation For Soft Anticholinergic Analogs | 22 May, 2034 | Active |
| US12398102 | Formulation For Soft Anticholinergic Analogs | 22 May, 2034 | Active |
| US10383846 | Method of dosing and use of soft anticholinergic esters | 14 Mar, 2034 | Active |
| US9220707 | Method of dosing and use of soft anticholinergic esters | 14 Mar, 2034 | Active |
| US9492429 | Method of dosing and use of soft anticholinergic esters | 14 Mar, 2034 | Active |
| US9895350 | Method of dosing and use of soft anticholinergic esters | 14 Mar, 2034 | Active |
| US8147809 | Soft anticholinergic esters | 26 Mar, 2027 | Active |
| US8628759 | Soft anticholinergic esters | 13 Nov, 2026 | Active |
Latest Legal Activities on Botanix Sb's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Botanix Sb.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Recordation of Patent Grant Mailed | 02 Sep, 2025 | US12398102 |
| transaction for FDA Determination of Regulatory Review Period | 26 Aug, 2025 | US9492429 |
| transaction for FDA Determination of Regulatory Review Period | 26 Aug, 2025 | US9220707 |
| Recordation of Patent eGrant | 26 Aug, 2025 | US12398102 |
| transaction for FDA Determination of Regulatory Review Period | 26 Aug, 2025 | US11026919 |
| transaction for FDA Determination of Regulatory Review Period | 26 Aug, 2025 | US8147809 |
| Information Disclosure Statement (IDS) Filed | 26 Aug, 2025 | US11034652 |
| Email Notification | 26 Aug, 2025 | US12398102 |
| Patent Issue Date Used in PTA Calculation | 26 Aug, 2025 | US12398102 |
| Patent eGrant Notification | 26 Aug, 2025 | US12398102 |
| transaction for FDA Determination of Regulatory Review Period | 26 Aug, 2025 | US8628759 |
| transaction for FDA Determination of Regulatory Review Period | 26 Aug, 2025 | US11034652 |
| Information Disclosure Statement (IDS) Filed | 26 Aug, 2025 | US11026919 |
| Mail Patent eGrant Notification | 26 Aug, 2025 | US12398102 |
| Email Notification | 20 Aug, 2025 | US12398102 |
Botanix Sb's Family Patents
Botanix Sb Drug List
Given below is the complete list of Botanix Sb's drugs and the patents protecting them.
1. Sofdra
Sofdra is protected by 20 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11566000 | Crystalline form of sofpironium bromide and preparation method thereof |
22 May, 2040
(14 years from now)
| Active |
| US11584715 | Crystalline form of sofpironium bromide and preparation method thereof |
22 May, 2040
(14 years from now)
| Active |
| US11123325 | Formulation for soft anticholinergic analogs |
20 Jul, 2037
(11 years from now)
| Active |
| US10947192 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US10952990 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US10959983 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US10961191 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US11026919 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US11034652 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US11052067 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US11084788 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US12156865 | Formulation for soft anticholinergic analogs |
22 May, 2034
(8 years from now)
| Active |
| US12357609 | Formulation For Soft Anticholinergic Analogs |
22 May, 2034
(8 years from now)
| Active |
| US12398102 | Formulation For Soft Anticholinergic Analogs |
22 May, 2034
(8 years from now)
| Active |
| US10383846 | Method of dosing and use of soft anticholinergic esters |
14 Mar, 2034
(8 years from now)
| Active |
| US9220707 | Method of dosing and use of soft anticholinergic esters |
14 Mar, 2034
(8 years from now)
| Active |
| US9492429 | Method of dosing and use of soft anticholinergic esters |
14 Mar, 2034
(8 years from now)
| Active |
| US9895350 | Method of dosing and use of soft anticholinergic esters |
14 Mar, 2034
(8 years from now)
| Active |
| US8147809 | Soft anticholinergic esters |
26 Mar, 2027
(1 year, 12 days from now)
| Active |
| US8628759 | Soft anticholinergic esters |
13 Nov, 2026
(8 months from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Sofdra's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List